中西医结合心脑血管病杂志
中西醫結閤心腦血管病雜誌
중서의결합심뇌혈관병잡지
Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease
2015年
16期
1825-1827
,共3页
郭炜%王肖龙%崔松%金涛%王慧颖%薛金贵%周华
郭煒%王肖龍%崔鬆%金濤%王慧穎%薛金貴%週華
곽위%왕초룡%최송%금도%왕혜영%설금귀%주화
冠心病%畅心饮%尿微量白蛋白%血管紧张素Ⅱ
冠心病%暢心飲%尿微量白蛋白%血管緊張素Ⅱ
관심병%창심음%뇨미량백단백%혈관긴장소Ⅱ
coronary heart disease%Changxinyin decoction%albuminuria%angiotensin Ⅱ
目的:观察畅心饮治疗对冠心病患者尿微量白蛋白(UACR)、血清血管紧张素Ⅱ(AngⅡ)水平的影响,探讨其对血管内皮的保护作用,以及这种保护作用与抗血管紧张素Ⅱ(AngⅡ)水平的关系。方法将86例冠心病患者分为两组,对照组行规范西医治疗,治疗组行规范西医治疗基础上加用畅心饮口服。观察两组临床疗效及治疗前后尿微量白蛋白和血清 AngⅡ水平的变化。结果治疗组临床疗效总有效率为76.1%,高于对照组的52.5%,差异有统计学意义(P<0.05);治疗组治疗后与治疗前及对照组治疗后相比,UACR、AngⅡ水平显著下降(P<0.05),各组尿微量白蛋白和血清 AngⅡ之间均存在着显著的相关性。结论对已经进行规范西医治疗的冠心病患者,畅心饮可进一步改善对血管内皮的保护作用,其机制与调控 AngⅡ水平有关。
目的:觀察暢心飲治療對冠心病患者尿微量白蛋白(UACR)、血清血管緊張素Ⅱ(AngⅡ)水平的影響,探討其對血管內皮的保護作用,以及這種保護作用與抗血管緊張素Ⅱ(AngⅡ)水平的關繫。方法將86例冠心病患者分為兩組,對照組行規範西醫治療,治療組行規範西醫治療基礎上加用暢心飲口服。觀察兩組臨床療效及治療前後尿微量白蛋白和血清 AngⅡ水平的變化。結果治療組臨床療效總有效率為76.1%,高于對照組的52.5%,差異有統計學意義(P<0.05);治療組治療後與治療前及對照組治療後相比,UACR、AngⅡ水平顯著下降(P<0.05),各組尿微量白蛋白和血清 AngⅡ之間均存在著顯著的相關性。結論對已經進行規範西醫治療的冠心病患者,暢心飲可進一步改善對血管內皮的保護作用,其機製與調控 AngⅡ水平有關。
목적:관찰창심음치료대관심병환자뇨미량백단백(UACR)、혈청혈관긴장소Ⅱ(AngⅡ)수평적영향,탐토기대혈관내피적보호작용,이급저충보호작용여항혈관긴장소Ⅱ(AngⅡ)수평적관계。방법장86례관심병환자분위량조,대조조행규범서의치료,치료조행규범서의치료기출상가용창심음구복。관찰량조림상료효급치료전후뇨미량백단백화혈청 AngⅡ수평적변화。결과치료조림상료효총유효솔위76.1%,고우대조조적52.5%,차이유통계학의의(P<0.05);치료조치료후여치료전급대조조치료후상비,UACR、AngⅡ수평현저하강(P<0.05),각조뇨미량백단백화혈청 AngⅡ지간균존재착현저적상관성。결론대이경진행규범서의치료적관심병환자,창심음가진일보개선대혈관내피적보호작용,기궤제여조공 AngⅡ수평유관。
Objective To investigate the effects of Changxinyin decoction(CXYD)on the levels of albuminuria and serum angiotensinⅡ in patients with coronary heart disease(CHD).Methods Eighty six patients with CHD were randomly divided into two groups:The control group treated with routine treatment,and the treatment group treated with routine treatment plus CXYD.The clinical effica-cy,albuminuria and serum angiotensin Ⅱlevels were observed. Results The total clinical effective rate was 76. 1% in treatment group,which was higher than that in control group(52.5%,P<0.05).After treatment,the levels of albuminuria and serum angiotensinⅡ in treatment group were decreased,which was lower than that in control group(P<0.05).In addition,the albuminuria level dem-onstrated a significant relation to serum angiotensinⅡ level in each groups.Conclusion CXYD can furthere improve the clinical effi-cacy and ameliorate vascular endothelial protection in patients with CHD,and this protection is significantly related to their angioten-sin Ⅱlevels.